These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 1577071)
61. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition. Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163 [TBL] [Abstract][Full Text] [Related]
62. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Buckner FS; Wipke BT; Van Voorhis WC Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608 [TBL] [Abstract][Full Text] [Related]
63. Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL. Falk K; Rötzschke O; Faath S; Goth S; Graef I; Shastri N; Rammensee HG Cell Immunol; 1993 Sep; 150(2):447-52. PubMed ID: 8370082 [TBL] [Abstract][Full Text] [Related]
64. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes. Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437 [TBL] [Abstract][Full Text] [Related]
65. Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man. Falk K; Rötzschke O; Rammensee HG Eur J Immunol; 1992 May; 22(5):1323-6. PubMed ID: 1577071 [TBL] [Abstract][Full Text] [Related]